Primary large cell neuroendocrine carcinoma of the breast with metastasis in the lymph nodes: a case report and literature review [0.03%]
原发性乳腺大细胞神经内分泌癌合并淋巴结转移的病例报告及文献复习
HongYan Li,MaoTao He,HengMing Zhang et al.
HongYan Li et al.
Primary large cell neuroendocrine carcinoma (LCNEC) of the breast is an extremely rare and diagnostically challenging subtype. A 47-year-old female was admitted to Weifang People's Hospital (Weifang, China) with a left breast mass that was ...
Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma [0.03%]
人乳头瘤病毒阴性咽鳞癌不同 subsite 对诱导化疗免疫治疗的反应益处分析研究论文
Lin Zhu,Die Zhang,Jie Chen et al.
Lin Zhu et al.
Purpose: To evaluate whether the addition of immune checkpoint inhibitors (ICIs) to induction chemotherapy improves outcomes in HPV-negative oropharyngeal squamous cell carcinoma (OPSCC), and whether efficacy differs by p...
Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis [0.03%]
表没食子儿茶素-3-棓酸通过miR-27a/Wnt/β-catenin轴抑制乳腺致癌性
Shrila Banerjee,Abul Kalam Azad Mandal
Shrila Banerjee
Introduction: Breast cancer is a global health concern with increased chemotherapeutic side effects and escalated chemoresistance, requiring alternative therapies. Epigallocatechin-3-gallate (EGCG), a bioactive green tea ...
Oncology research in the kingdom of Bahrain: a four-decade bibliometric evolution [0.03%]
巴林王国的肿瘤学研究:40年文献计量演变历程
Randah R Hamadeh,Enjy Khedr,Haitham Jahrami
Randah R Hamadeh
Introduction: Bahrain reports the highest age-standardized cancer incidence among Gulf Cooperation Council (GCC) countries, but its oncology research output has not been comprehensively mapped. We profiled four decades of...
Editorial: Challenges and strategies in the management of ER/PgR Low-expression breast cancer: exploring fundamentals, clinical insights, and treatment approaches [0.03%]
编辑评论:低ER/PgR表达型乳腺癌的挑战与策略——探索基础、临床及治疗路径
Takashi Takeshita,Vittorio Gebbia,San-Gang Wu
Takashi Takeshita
Glioma management and outcome in low-middle-income countries: a systematic review [0.03%]
低收入和中等收入国家的胶质瘤管理及预后系统评价
Adam M Abdallah,Atef F Hulliel,Asem A Almomani et al.
Adam M Abdallah et al.
Background: Gliomas are the most common primary malignant brain tumors, yet evidence on their management and outcomes in low- and middle-income countries (LMICs) remains limited. Disparities in diagnostic capacity, treatm...
Imaging features and differentiation between benign and malignant Brenner tumors in a multi-center cohort [0.03%]
良性与恶性布伦纳肿瘤的影像学特征及鉴别(多中心队列)
Tao Zhou,Peng Xia,Qinghai Miao et al.
Tao Zhou et al.
Objective: To explore the imaging features of histopathologically confirmed ovarian Brenner tumors (BTs) and to improve the accuracy of differential diagnosis between benign and borderline or malignant variants. ...
Case Report: First occurrence of smoldering multiple myeloma in activated phosphoinositide 3-Kinase δ syndrome [0.03%]
病例报告:活化磷脂酰肌醇-3-激酶δ综合征中首次出现冒烟型多发性骨髓瘤
Yanqiu Li,Linlin Huang,Wenhua He et al.
Yanqiu Li et al.
Activated phosphoinositide 3-kinase δ syndrome (APDS) is a newly described inborn error of immunity. Heterozygous mutations in the PI3Kδ catalytic subunit p110δ (PIK3CD) or regulatory subunit p85α (PIK3R1) lead to APDS1 and APDS2, respe...
Risk factors for conversion to mastectomy due to positive margins in early breast cancer patients when choosing breast-conserving surgery: a retrospective cohort study [0.03%]
保乳术后阳性切缘转为乳房切除术的危险因素分析:一项回顾性队列研究
Ning-Chen Wang,Xing Zhang,Yuan-Yuan Xu
Ning-Chen Wang
Background: Breast-conserving surgery (BCS) offers oncologic safety and a superior quality of life for patients with early breast cancer (BC). However, conversion to mastectomy (CMT) owing to positive margins remains unav...
Viable CAR T-cells remain detectable in cerebrospinal fluid in patients with grade ≥3 ICANS despite corticosteroid therapy [0.03%]
类固醇治疗难治性≥3级CAR T细胞诱导的神经毒性患者的脑脊液中仍可检测到活性CAR T细胞
Alexander Casimir Angleitner,Markus Maulhardt,Gerald Wulf et al.
Alexander Casimir Angleitner et al.
Background: Immune effector cell-associated neurotoxicity syndrome (ICANS) is a severe complication of CAR T-cell therapy. Although CAR T-cells have been detected in cerebrospinal fluid (CSF), their viability remains unkn...